Our Clinical Trials

Use of ‘Plozasiran’ in Adults with Severe Hypertriglyceridemia (SHASTA-3 Study)

Phase 3 placebo-control study assessing the efficacy and safety of Plozasiran on the reduction of triglyceride levels in adults with severe hypertriglyceridemia. If you have hypertriglyceridemia and are currently prescribed a lipid-lowering medication, you might be eligible for this 58-week study.

This study is being conducted at our Western Sydney site.

Apply Now
Placeholder Image

Use of ‘Plozasiran’ in Adults with Mild-Moderate Hypertriglyceridemia (MUIR-3 STUDY)

Phase 3 placebo-control study assessing the efficacy and safety of Plozasiran on the reduction of triglyceride levels in adults with mild-moderate hypertriglyceridemia. If you have hypertriglyceridemia and are currently prescribed a lipid-lowering medication, you might be eligible for this 15-month study.

This study is being conducted at our Western Sydney site only.

Apply Now
Placeholder Image
1 2 3 4